Key Points
-
The prevalence of Paget's disease has decreased in many countries
-
A large number of patients have a family history of Paget's disease
-
Mutations in SQSTM1 (which encodes sequestosome-1) account for the susceptibility to develop Paget's disease in some families
-
Some studies in patients with Paget's disease and in transgenic mice support the involvement of measles virus in the aetiology of the disorder
-
The availability of effective measles vaccines since 1963 might explain the decrease in diagnosis of Paget's disease in a number of countries
Abstract
Paget's disease of bone is generally diagnosed in individuals aged >50 years, usually manifests in one or several bones and is initiated by osteoclast-induced osteolytic lesions. Subsequently, over a period of many years, osteoblastic activity can result in sclerosis and deformation of bone. The prevalence of Paget's disease is highest in the UK and in countries where a large number of residents have ancestors from the UK. Currently, in many countries, the prevalence of the disorder has decreased. A considerable number of affected patients have a family history of Paget's disease and the disorder has an autosomal dominant pattern of inheritance but with incomplete penetrance. A large number of mutations in SQSTM1 (which encodes sequestosome-1; also known as ubiquitin-binding protein p62) seem to account for the susceptibility to develop Paget's disease in some families; the involvement of other genes is currently under investigation. In addition to a genetic cause, environmental factors have been proposed to have a role in the pathogenesis of Paget's disease. Although most evidence has been presented for measles virus as an aetiologic factor, some studies have not confirmed its involvement. The decreasing incidence of Paget's disease, which could be attributed to measles vaccination along with the measles virus nucleocapsid protein induction of Paget's disease lesions in transgenic mice, supports an aetiologic role of the virus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Paget, J. On a form of chronic inflammation of bones (osteitis deformans). Med. Chir. Trans. 60, 37–64. 9 (1877).
Corral-Gudino, L., Borao-Cengotita-Bengoa, M., Del Pino-Montes, J. & Ralston, S. Epidemiology of Paget's disease of bone: a systematic review and meta-analysis of secular changes. Bone 55, 347–352 (2013).
Rontgen, W. C. Uber eine neue Art von Strahlen [German]. (Sitzberichte der Wurzburger Physikalischen-Medinischen Gesellshaft, 1895).
Schmorl, G. Uber ostitis deformans Paget [German]. Virchow Arch. Pathol. Anat. Physiol. Klin. Med. 283, 694–751 (1932).
Kay, H. D. Plasma phosphatase in osteitis deformans and in other disease of bone. Br. J. Exp. Pathol. 10, 253–256 (1929).
Shankar, S. & Hosking, D. J. Biochemical assessment of Paget's disease of bone. J. Bone Miner. Res. 21 (Suppl. 2), P22–P27 (2006).
Maldague, B. & Malghem, J. Dynamic radiologic patterns of Paget's disease of bone. Clin. Orthop. Relat. Res. 217, 126–151 (1987).
Rebel, A., Malkani, K. & Basle, M. Nuclear anomalies in osteoclasts in Paget's bone disease [French]. Nouv. Presse Med. 3, 1299–1301 (1974).
Mills, B. G. & Singer, F. R. Nuclear inclusions in Paget's disease of bone. Science 194, 201–202 (1976).
Renier, J. C. & Audran, M. Progression in length and width of pagetic lesions and estimation of age at disease onset. Rev. Rhum. Engl. Ed. 64, 35–43 (1997).
Corral-Gudino, L. et al. Secular changes in Paget's disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain. Osteoporos. Int. 24, 443–450 (2013).
Gennari, L., Merlotti, D., Martini, G. & Nuti, R. Paget's disease of bone in Italy. J. Bone Miner. Res. 21, 14–21 (2006).
Pick, A. Osteitis deformans. Lancet 2, 1125–1126 (1883).
Siris, E. S., Ottman, R., Flaster, E. & Kelsey, J. L. Familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 6, 495–500 (1991).
Sofaer, J. A., Holloway, S. M. & Emery, A. E. A family study of Paget's disease of bone. J. Epidemiol. Community Health 37, 226–231 (1983).
Morales-Piga, A. A., Rey-Rey, J. S., Corres-Gonzalez, J., Garcia-Sagredo, J. M. & Lopez-Abente, G. Frequency and characteristics of familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 10, 663–670 (1995).
Laurin, N., Brown, J. P., Morissette, J. & Raymond, V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70, 1582–1588 (2002).
Rea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T. & Xu, J. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone. Endocr. Rev. 34, 501–524 (2013).
Morissette, J., Laurin, N. & Brown, J. P. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J. Bone Miner. Res. 21 (Suppl. 2), P38–P44 (2006).
Lucas, G. J. et al. Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descent. J. Bone Miner. Res. 20, 227–231 (2005).
Chung, P. Y. et al. Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's disease of bone. Calcif. Tissue Int. 83, 34–42 (2008).
Michou, L. et al. Novel SQSTM1 mutations in patients with Paget's disease of bone in an unrelated multiethnic American population. Bone 48, 456–460 (2011).
Rhodes, E. C. et al. Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States. Calcif. Tissue Int. 82, 271–277 (2008).
Goode, A. et al. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function. Biochim. Biophys. Acta 1842, 992–1000 (2014).
Visconti, M. R. et al. Mutations of SQSTM1 are associated with severity and clinical outcome in Paget disease of bone. J. Bone Miner. Res. 25, 2368–2373 (2010).
Bolland, M. J. et al. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J. Bone Miner. Res. 22, 411–415 (2007).
Cundy, T., Rutland, M. D., Naot, D. & Bolland, M. Evolution of Paget's disease of bone in adults inheriting SQSTM1 mutations. Clin. Endocrinol. (Oxf.) http://dx.doi.orh/10.1111/cen.12741.
Chung, P. Y. Paget's disease of bone: evidence for complex pathogenetic interactions. Semin. Arthritis Rheum. 41, 619–641 (2012).
Beauregard, M. et al. Identification of rare genetic variants in novel loci associated with Paget's disease of bone. Hum. Genet. 133, 755–768 (2014).
Vallet, M. et al. Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of bone. Hum. Mol. Genet. 24, 3286–3295 (2015).
Chung, P. Y. et al. The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum. Genet. 128, 615–626 (2010).
Gianfrancesco, F. et al. A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease. J. Bone Miner. Res. 27, 443–452 (2012).
Gianfrancesco, F. et al. Giant cell tumor occuring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree. J. Bone Miner. Res. 28, 341–350 (2013).
Whyte, M. P., Reinus, W. R., Podgornik, M. N. & Mills, B. G. Familial expansile osteolysis (excessive RANK effect) in a 5-generation American kindred. Medicine (Baltimore) 81, 101–121 (2002).
Dickson, G. R. et al. Familial expansile osteolysis: a morphological, histomorphometric and serological study. Bone 12, 331–338 (1991).
Whyte, M. P. & Hughes, A. E. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J. Bone Miner. Res. 17, 26–29 (2002).
Nakatsuka, K., Nishizawa, Y. & Ralston, S. H. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J. Bone Miner. Res. 18, 1381–1385 (2003).
Ke, Y.-H., Yue, H., He, J.-W., Liu, Y.-J. & Zhang, Z.-L. Early onset Paget's disease of bone caused by a novel mutation (78dup27) of the TNFRSF11A gene in a Chinese family. Acta Pharmacol. Sin. 30, 1204–1210 (2009).
Whyte, M. P. et al. Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347, 175–184 (2002).
Whyte, M. P. et al. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK. Bone 68, 153–161 (2014).
Rea, S. L. et al. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-κB signaling without loss of ubiquitin binding. J. Bone Miner. Res. 24, 1216–1223 (2009).
Falchetti, A. et al. Genetic epidemiology of Paget's disease of bone in Italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone. Calcif. Tissue Int. 84, 20–37 (2009).
Beyens, G. et al. Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif. Tissue Int. 75, 144–152 (2004).
Merchant, A. et al. Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone. J. Bone Miner. Res. 24, 484–494 (2009).
Matthews, B. G. et al. Absence of somatic SQSTM1 mutations in Paget's disease of bone. J. Clin. Endocrinol. Metab. 94, 691–694 (2009).
Guay-Belanger, S. et al. Detection of SQSTM1/P392L post-zygotic mutations in Paget's disease of bone. Hum. Genet. 134, 53–65 (2015).
Fecto, F. et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440–1446 (2011).
Kwok, C. T., Morris, A. & de Belleroche, J. S. Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur. J. Hum. Genet. 22, 492–496 (2014).
Marangi, G. & Traynor, B. J. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 1607, 75–93 (2015).
Geetha, T., Vishwaprakash, N., Sycheva, M. & Babu, J. R. Sequestosome 1/p62: across diseases. Biomarkers 17, 99–103 (2012).
Weihl, C. C., Pestronk, A. & Kimonis, V. E. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 19, 308–315 (2009).
Tresse, E. et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217–227 (2010).
Chung, P. Y. et al. Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms. Mol. Genet. Metab. 103, 287–292 (2011).
Lucas, G. J. et al. Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 38, 280–285 (2006).
Kimonis, V. E. et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A 146A, 745–757 (2008).
Kurihara, N. et al. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J. Clin. Invest. 117, 133–142 (2007).
Kurihara, N. et al. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62 (P392L) mutation to Paget's disease. Cell Metab. 13, 23–34 (2011).
Daroszewska, A. et al. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Hum. Mol. Genet. 20, 2734–2744 (2011).
Custer, S. K., Neumann, M., Lu, H., Wright, A. C. & Taylor, J. P. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 19, 1741–1755 (2010).
Badadani, M. et al. VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS ONE 5, e13183 (2010).
Nalbandian, A. et al. The homozygote VCPR155H/R155H mouse model exhibits accelerated human VCP-associated disease pathology. PLoS ONE 7, e46308 (2012).
Lever, J. H. Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone 31, 434–436 (2002).
Spencer, H., O'Sullivan, V. & Sontag, S. J. Exposure to lead, a potentially hazardous toxin: Paget's disease of bone. J. Trace Elem. Exper. Med. 8, 163–171 (1995).
Barker, D. J., Chamberlain, A. T., Detheridge, F. M., Gardner, M. J. & Guyer, P. B. Low lead levels in pagetoid bone. Metab. Bone Dis. Relat. Res. 4, 243–247 (1982).
Adachi, J. D. et al. Is there any association between the presence of bone disease and cumulative exposure to lead? Calcif. Tissue Int. 63, 429–432 (1998).
O'Driscoll, J. B. & Anderson, D. C. Past pets and Paget's disease. Lancet 2, 919–921 (1985).
O'Driscoll, J. B., Buckler, H. M., Jeacock, J. & Anderson, D. C. Dogs, distemper and osteitis deformans: a further epidemiological study. Bone Miner. 11, 209–216 (1990).
Lopez-Abente, G., Morales-Piga, A., Elena-Ibanez, A., Rey-Rey, J. S. & Corres-Gonzalez, J. Cattle, pets, and Paget's disease of bone. Epidemiology 8, 247–251 (1997).
Holdaway, I. M., Ibbertson, H. K., Wattie, D., Scragg, R. & Graham, P. Previous pet ownership and Paget's disease. Bone Miner. 8, 53–58 (1990).
Renier, J. C., Fanello, S., Bos, C. & Audran, M. An etiologic study of Paget's disease. Rev. Rhum. Engl. Ed. 63, 606–611 (1996).
Siris, E. S., Kelsey, J. L., Flaster, E. & Parker, S. Paget's disease of bone and previous pet ownership in the United States: dogs exonerated. Int. J. Epidemiol. 19, 455–458 (1990).
Gennari, L. et al. SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J. Bone Miner. Res. 25, 1375–1384 (2010).
Harvey, l. et al. Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral etiology. J. Clin. Pathol. 35, 771–779 (1982).
Howatson, A. F. & Fornasier, V. L. Microfilaments associated with Paget's disease of bone: comparison with nucleocapsids of measles virus and respiratory syncytial virus. Intervirology 18, 150–159 (1982).
Gherardi, G., LoCascio, V. & Bonucci, E. Fine structure of nuclei and cytoplasm of osteoclasts in Paget's disease of bone. Histopathologie 4, 63–74 (1980).
Schulz, A., Delling, G., Ringe, J. D. & Ziegler, R. Morbus Paget des knochens: untersuchungen zur ultrastruktur der osteoclasten und ihrer cytopathogenese [German]. Virchow Arch. A Pathol. Anat. Histopathol. 376, 309–328 (1977).
Mii, Y. et al. Electron microscopic evidence of a viral nature for osteoclast inclusions in Paget's disease of bone. Virchows Arch. 424, 99–104 (1994).
Abe, S. et al. Viral behavior of paracrystalline inclusions of osteoclasts of Paget's disease of bone. Ultrastruct. Pathol. 19, 455–461 (1995).
Baublis, J. V. & Payne, F. E. Measles antigen and syncytium formation in brain cell cultures from subacute sclerosing panencephalitis (SSPE). Proc. Soc. Exp. Biol. Med. 129, 593–597 (1968).
Singer, F. R. & Mills, B. G. Giant cell tumor arising in Paget's disease of bone. Recurrences after 36 years. Clin. Orthop. Relat. Res. 293, 293–301 (1993).
Schajowicz, F., Ubios, A. M., Araujo, E. S. & Cabrini, R. L. Virus-like intranuclear inclusions in giant cell tumor of bone. Clin. Orthop. Relat. Res. 201, 247–250 (1985).
Mills, B. G., Yabe, H. & Singer, F. R. Osteoclasts in human osteopetrosis contain viral-nucleocapsid-like nuclear inclusions. J. Bone Miner. Res. 3, 101–106 (1988).
Beneton, M. N., Harris, S. & Kanis, J. A. Paramyxovirus-like inclusions in two cases of pycnodysostosis. Bone 8, 211–217 (1987).
Bianco, P., Silvestrini, G., Ballanti, P. & Bonucci, E. Paramyxovirus-like nuclear inclusions identical to those of Paget's disease of bone detected in giant cells of primary oxalosis. Virchows Arch. A Pathol. Anat. Histopathol. 421, 427–433 (1992).
Rebel, A. et al. Viral antigens in osteoclasts from Paget's disease of bone. Lancet 2, 344–346 (1980).
Mills, B. G. et al. Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin. Orthop. Relat. Res. 183, 303–311 (1984).
Mills, B. G., Singer, F. R., Weiner, L. P. & Holst, P. A. Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone. Proc. Natl Acad. Sci. USA 78, 1209–1213 (1981).
Mills, B. G. et al. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens. Bone 15, 443–448 (1994).
Helfrich, M. H. et al. A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J. Bone Miner. Res. 15, 2315–2329 (2000).
Basle, M. F., Fournier, J. G., Rozenblatt, S., Rebel, A. & Bouteille, M. Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J. Gen. Virol. 67, 907–913 (1986).
Reddy, S. V., Singer, F. R. & Roodman, G. D. Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J. Clin. Endocrinol. Metab. 80, 2108–2111 (1995).
Reddy, S. V., Singer, F. R., Mallette, L. & Roodman, G. D. Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J. Bone Miner. Res. 11, 1602–1607 (1996).
Friedrichs, W. E. et al. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J. Bone Miner. Res. 17, 145–151 (2002).
Birch, M. A. et al. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J. Bone Miner. Res. 9, 11–16 (1994).
Ooi, C. G., Walsh, C. A., Gallagher, J. A. & Fraser, W. D. Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27, 417–421 (2000).
Matthews, B. G. et al. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease. J. Clin. Endocrinol. Metab. 93, 1398–1401 (2008).
Kurihara, N., Zhou, H. & Reddy, S. V. Expression of measle virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J. Bone Miner. Res. 21, 446–455 (2006).
Galson, D. & Roodman, G. D. Pathobiology of Paget's disease of bone. J. Bone Metab. 21, 85–98 (2014).
Teramachi, J. et al. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J. Bone Miner. Res. 29, 1456–1465 (2014).
Sundaram, K., Senn, J., Sandamban, Y., Rao, D. S. & Reddy, S. V. FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Mol. Endocrinol. 23, 1445–1454 (2009).
Enders, J. F. Vaccination against measles. Aust. J. Exp. Biol. Med. Sci. 41 (Suppl.), 467–489 (1963).
Filia, A. et al. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal. Euro. Surveill. 18, 20480 (2013).
Mayoral Cortes, J. et al. Measles outbreak in Andulasia, Spain, January to August 2011. Euro. Surveill. 17, 20300 (2012).
Mee, A. P. et al. Detection of canine distemper virus in 100% of Paget's disease samples by in-situ-reverse-transcriptase-polymerase chain reaction. Bone Miner. 23, 171–175 (1998).
Selby, P. L., Davies, M. & Mee, A. P. Canine distemper virus induces human osteoclastogenesis through NF-κB and sequestosome 1/P62 activation. J. Bone Miner. Res. 21, 1750–1756 (2006).
Gordon, M. T. et al. Prevalence of canine distemper antibodies in the pagetic population. J. Med. Virol. 40, 313–317 (1993).
Delage, G. et al. Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch. Pathol. Lab. Med. 108, 623–625 (1984).
Radoycich, G. E., Zuppan, C. W., Weeks, D. A., Krous, H. F. & Langston, C. Patterns of measles pneumonitis. Pediatr. Pathol. 12, 773–786 (1992).
Albagha, O. M. et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat. Genet. 42, 520–524 (2010).
Albagha, O. M. et al. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat. Genet. 43, 685–689 (2011).
Donath, J. et al. Vitamin D receptor, oestrogen receptor-α and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone. Rheumatology (Oxford) 43, 692–695 (2004).
Wuyts, W. et al. Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28, 104–107 (2001).
Michou, L. et al. Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone. Bone 51, 720–728 (2012).
Beauregard, M. et al. Genetic association study of Dickkopf-1 and sclerostin genes with Paget disease of bone. Calcif. Tissue Int. 93, 405–412 (2013).
Christopher, P. J., MacDonald, P. A., Murphy, A. M. & Buckley, P. R. Measles in the 1980s. Med. J. Aust. 2, 488–491 (1983).
Sutherland, I. & Fayers, P. M. Effect of measles vaccination on incidence of measles in the community. Br. Med. J. 1, 698–702 (1971).
Reinert, P., Soubeyrand, B. & Gauchoux, R. 35-year measles, mumps, rubella vaccination assessment in France. Arch. Pediatr. 10, 948–954 (2003).
Cullen, R. M. & Walker, W. J. Measles epidemics 1949–1991: the impact of mass immunisation in New Zealand. N. Z. Med. J. 109, 400–402 (1996).
van der Zwan, C. W., Plantinga, A. D., Rumke, H. C. & Conyn-van-Spaendonck, M. A. Measles in the Netherlands; epidemiology and the effect of vaccination [Dutch]. Ned. Tijdschr. Geneeskd. 138, 2390–2395 (1994).
Acknowledgements
F.R.S. acknowledges G. Berry, E. Moreno and D. Marzese for technical support, and Eli and Edythe Broad and Lois Rosen for grant support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Singer, F. Paget's disease of bone—genetic and environmental factors. Nat Rev Endocrinol 11, 662–671 (2015). https://doi.org/10.1038/nrendo.2015.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2015.138
This article is cited by
-
Metabolic bone disorders and the promise of marine osteoactive compounds
Cellular and Molecular Life Sciences (2024)
-
Targeting strategies for bone diseases: signaling pathways and clinical studies
Signal Transduction and Targeted Therapy (2023)
-
Attenuated clinical and osteoclastic phenotypes of Paget’s disease of bone linked to the p.Pro392Leu/SQSTM1 mutation by a rare variant in the DOCK6 gene
BMC Medical Genomics (2022)
-
Insights into skeletal stem cells
Bone Research (2022)
-
Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology
Current Allergy and Asthma Reports (2021)